REGENERON PHARMACEUTICALS INC.

Lobbying client · New York · filed 2025 to 2026

Pharmaceutical company

$480,000 Reported spend

7 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page is grouped by the client's LDA id (65271), not by name.

Firms hired 1

CHECKMATE GOVERNMENT RELATIONS $480,000 7 filings

Reported by year 2 years

2026 $180,000 2 filings
2025 $300,000 5 filings

Issues lobbied 1

Health Issues 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

Health & Human Services, Dept of (HHS) 6
Centers For Medicare and Medicaid Services (CMS) 3
Treasury, Dept of 2
White House Office 2
Food & Drug Administration (FDA) 1

Recent filings 7 total

Q2

CHECKMATE GOVERNMENT RELATIONS

2nd Quarter (Apr 1 - June 30) 2026 · $90,000 income · posted Jul 15, 2026

View → Q1

CHECKMATE GOVERNMENT RELATIONS

1st Quarter (Jan 1 - Mar 31) 2026 · $90,000 income · posted Apr 15, 2026

View → Q4

CHECKMATE GOVERNMENT RELATIONS

4th Quarter (Oct 1 - Dec 31) 2025 · $90,000 income · posted Jan 20, 2026

View → Q3

CHECKMATE GOVERNMENT RELATIONS

3rd Quarter (July 1 - Sep 30) 2025 · $90,000 income · posted Oct 20, 2025

View → Q2

CHECKMATE GOVERNMENT RELATIONS

2nd Quarter (Apr 1 - June 30) 2025 · $90,000 income · posted Jul 20, 2025

View → Q1

CHECKMATE GOVERNMENT RELATIONS

1st Quarter (Jan 1 - Mar 31) 2025 · $30,000 income · posted Apr 21, 2025

View → RR

CHECKMATE GOVERNMENT RELATIONS

1st Quarter (Jan 1 - Mar 31) 2025 · posted Mar 27, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.